GGrantIndex
Sort

130,381 grants matching hiv

Adherence Intervention for HIV + Alcohol Users

$999,366
Hunter College · R01 · FY2003 · AA

Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials

$999,334
Kejian Yang · Biomedical Research Models, Inc. · R44 · FY2015 · AI

Cell-type based epigenomic analysis to identify druggable genes for people living with HIV infection and using cannabis

$999,317
Ke Xu · Yale University · R01 · FY2025 · DA

Rapid point-of-care molecular test for HCV VL

$999,310
Jay Kenneth Fisher · Redbud Labs, Inc. · R44 · FY2024 · AI

CENTER FOR METABOLIC RESEARCH ON HIV AND DRUG USE

$999,262
Tufts University Boston · P30 · FY2002 · DA

Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC)

$999,186
George R Seage · Harvard School Of Public Health · U01 · FY2010 · HD

PS24-040 UPLIFT Study (Understanding Parental Lactation and Infant Feeding decisions Tailored to people with HIV.\")

$999,128
Lisa Lynn Abuogi · University Of Colorado Denver · U01 · FY2024 · PS

San Diego Export: An University Community Partnership E*

$999,116
University Of California San Diego · P60 · FY2003 · MD

AWI-Gen Phase 2: Genomic and environmental risk factors for cardiometabolic disease in Africans

$999,112
Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2019 · HG

Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND

$999,102
Mary B Weitzel · Yaso Therapeutics Inc · R44 · FY2019 · HD

Programatic-Strengthening Medical Education for Improved Health Outcomes in Kenya

$999,000
James Njogu Kiarie · University Of Nairobi · R24 · FY2011 · TW

Mechanisms of Drug Disposition During Pregnancy

$998,989
Jashvant D Unadkat · University Of Washington · P01 · FY2017 · DA

Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies

$998,985
Milen Kirilov · Ingenious Targeting Laboratory, Inc. · R44 · FY2022 · AI

PS24-040 UPLIFT Study (Understanding Parental Lactation and Infant Feeding decisions Tailored to people with HIV.\\\")

$998,932
Lisa Lynn Abuogi · University Of Colorado Denver · U01 · FY2025 · PS

Development of a kit for the targeted depletion of abundant sequencesfromDNA/RNA libraries

$998,921
Meredith Lauren Carpenter · Arc Bio, Llc · R44 · FY2019 · AI

Development of a kit for the targeted depletion of abundant sequencesfromDNA/RNA libraries

$998,921
Meredith Lauren Carpenter · Arc Bio, Llc · R44 · FY2018 · AI

Point Detection of Pathogens in Oral Samples via UPT

$998,906
University Of Pennsylvania · U01 · FY2002 · DE

Development of a Vaccine for HIV-AIDS: Cellular Immunity

$998,897
Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

NIAID Preclinical Development Support - Development of clade C Vaccine

$998,870
Phillip Ishikawa · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI

Pre-Clinical Development of a Intranasal Bivalent gD2/gB2 HSV-2 Mucosal Vaccine

$998,684
Ali I. Fattom · Bluewillow Biologics, Inc. · R44 · FY2020 · AI

Large Scale T Cell Epitope Discovery: Local and Systemic T cell Response to Herpes Simplex Virus

$998,672
Tim Myer · University Of Washington · N01 · FY2020 · AI

WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICATION?

$998,663
Michael David Alpert · Emmune, Inc · R44 · FY2018 · AI

HIV Research Program in Thailand and Cambodia

$998,662
Kiat Ruxrungtham · Hiv-Nat, The Thai Red Cross Aids Rch Ctr · U19 · FY2008 · AI

Building on Needle Exchange to Optimize HIV Prevention/Treatment

$998,636
Gregory M Lucas · Johns Hopkins University · R01 · FY2020 · DA

Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis

$998,500
Aaron Richard McCabe · Minnetronix, Inc. · R42 · FY2018 · AI